Publikationer i urval

Europeiska samarbetsprojekt
Studier av ärftliga tumörsjukdomar
Cancer i huvud-hals regionen och övre digestionskanalen
Malignt melanom

Ben- och mjukdelssarkom
Bröstcancer
Testistumörer
Thyreoideacancer
Maligna lymfom
Ovarialcancer

Barntumörer
Cancerrisk vid specifika exponeringar

Cancerförekomst vid vissa sjukdomar/medicinska åtgärder
Hälsoekonomi m m
Akademiska avhandlingar

EUROPEISKA SAMARBETSPROJEKT

Micheli A, Coebergh J W, Mugno E, Massimiliani E, Sant M, Oberaigner W, Holub J, Storm H H , Forman D, Quinn M, Aareleid T, Sankila T, Faivre J, Ziegler H, Tryggvadòttir L, Zanetti R, Dalmas M, Vissner O, Langmark F, Bielska-Lasota M, Wronkowski Z, Pinheiro P S , Brewster D H, Pleško I, Pompe-Kirn V, Martinez-Garcia C, Barlow L, Möller T, Lutz J M, André M, Steward J A: European health systems and cancer care. Ann Oncol 2003; 14 Suppl 5: 41-60.

Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J, Grosclaude P, Hédelin G, Matsuda T, Møller H, Möller T, Verdecchia A, Capocaccia R, Gatta G, Micheli A, Santaquilani M, Roazzi P, Lisi D, and the EUROCARE Working Group: EUROCARE-3: survival of cancer patients diagnosed 1990–94 — results and commentary. Ann Oncol 2003;14:61-118.

Möller T, Garwicz S, Corazziari I, Magnani C: Survival of children with liver tumours in Europe 1978-89. Eur J Ca 2001;37:744-749.

Quaglia A, Vercelli M, Lillini R, Mugno E, Coebergh JW, Quinn M, Martinez-Garcia C, Capocaccia R, Micheli A  and the ELDCARE Working Group: Socio-economic factors and health care system characteristics related to cancer survival in the elderly - A population-based analysis in sixteen European countries (ELDCARE project). Critical Reviews in Oncology 2005;54:117-128.

Gatta G, Ciccolallo L, Kunkler I, Capocaccia R, Berrino F, Casali p, Coleman M, De Angelis R, Faivre J, Lutz JM, Martinez C, Möller T, Sankila R and the EUROCARE Working Group: Survival from rare Cancer in Adults: a population-based study. The Lancet Oncology 2006;7:132-140.
Micheli A, Mugno E, Krogh V, Quinn MJ, Coleman M, Hakulinen T, Gatta G, Berrino F, Capocaccia R and the EUROPREVAL Working Group: Cancer prevalence in European registries areas. Annals of Oncology 2002;13:840-865.

Möller T, Anderson H, Aareleid T, Hakulinen T, Storm H, Tryggvadottir L, Corazziari I, Mugno E for the EUROPREVAL Working Group: Cancer prevalence in Northern Europe: The EUROPREVAL study. Annals of Oncology 2003;14:946-957. 

Gatta G, Capocaccia R, Berrino F, Ruzza, M R, Contiero P, and the EUROPREVAL Working Group: Colon cancer prevalence and estimation of differing care needs of colon cancer patients. Ann Oncol 2004; 15:1136-1142.

pilTillbaka upp
pil Tillbaka till Forskning

STUDIER AV ÄRFTLIGA TUMÖRSJUKDOMAR

Anderson H, Bladström A, Olsson H, Möller T: Familial Breast and Ovarian Cancer; A Swedish Population Based Register Study.Am J Epid 2000;152:1154-63.

Planck M, Anderson H, Bladström A, Möller T, Wenngren E, Olsson H: Increased cancer risk in offspring to women with colorectal carcinomar. Cancer 2000;89:741-749.

Ericson K, Nilbert M, Bladstrom A, Anderson H, Olsson H, Planck M. Familial risk of tumors associated with hereditary non-polyposis colorectal cancer: a Swedish population-based study. Scand J Gastroenterol 2004;39(12):1259-65.

Heimdal K, Olsson H, Tretli S, Flodgren P, Børresen A-L, Fosså SD. Risk of cancer in relatives to testicular cancer patients. Br J Cancer 1996;73(7):970-73. Heimdal K, Olsson H, Tretli S, Flodgren P, Børresen A-L, Fosså SD. Familial testicular cancer in Norway and southern Sweden. Br J Cancer 1996;73(7):964-69.

Heimdal K, Olsson H, Tretli S, Fossaa S, Børresen A-L, Bishop T. A segregation analysis of testicular cancer based on Norwegian and Swedish families. Br J Cancer 1997;75(7):1084-87.

Bratt O, Kristoffersson U, Lundgren R, Olsson H. The risk for malignant tumours in first-degree relatives of men with early onset prostate cancer. A population based cohort study. Eur J Cancer 1997;33(13):2237-40.

Bratt O, Kristoffersson U, Lundgren R, Olsson H. Familial and hereditary prostate cancer in southern Sweden. A population based case control study. Eur J Cancer 1999;35(2):272-77.

Johannsson OT, Ranstam J, Borg Å, Olsson H. Survival of BRCA1 breast and ovarian cancer patients: a population based study from southern Sweden. J Clin Oncol 1998;16(Feb):397-404.

Loman N, Johannsson O, Kristoffersson U, Olsson H, Borg Å. Family history and BRCA1/BRCA2 mutations in a population-based series of early onset breast cancer. J Natl Cancer Inst 2001;Aug 15;93(16):1215-23.

Loman N, Bladstrom A, Johannsson O, Borg A, Olsson H. Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status. Breast Cancer Res 2003;5(6):R175-86.

Antoniou A, Pharaoh P, Narod S, Risch H, Eyfjord J, Hopper J, Loman, N.; Olsson, H.; Johannsson, O.; Borg, Å.; Pasini, B.; Radice, P.; Monoukian, S.; Eccles, D.; Tung, N.; Olah, E.; Anton-Culver, H.; Warner, E.; Lubinski, J.; Gronwald, J.; Gorski, B.; Tulinius, H.; Thorlacius, S.; Eeerola, H.; Nevalinna, H.; Syrjäkoski, K.; Kallioniemi, O-P.; Thompson, D.; C., Evans; Peto, J.; Lalloo, F.; Evans, DG.; Easton, DF.
Average risks of breast and ovarian cancer associated with mutations in BRCA1 or BRCA2 detected in case series unselected for family history: a combined analysis of 22 studies. Am J Human Genetics 2003;May:72(5):1117-30.

Antoniou AC, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Olsson, H.; Johannsson, O.; Borg, A.; Pasini, B.; Radice, P.; Manoukian, S.; Eccles, D. M.; Tang, N.; Olah, E.; Anton-Culver, H.; Warner, E.; Lubinski, J.; Gronwald, J.; Gorski, B.; Tulinius, H.; Thorlacius, S.; Eerola, H.; Nevanlinna, H.; Syrjakoski, K.; Kallioniemi, O. P.; Thompson, D.; Evans, C.; Peto, J.; Lalloo, F.; Evans, D. G.; Easton, D. F.
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet 2005;42(7):602-3.

Narod S, Risch H, Moslehi R, Dörum A, Neuhausen S, Olsson H, Provencher, D.; Radice, P.; Evans, G.; Bishop, S.; Brunet, J-S.; Ponder, BAJ.; Group., Hereditary Ovarian Cancer Clinical Study   Oral contraceptives and the risk of hereditary ovarian cancer. N Engl J Med 1998;339:424-28.

Brohet R, Goldgar D, Easton DF, Antoniou AC, Andrieu N, Chang-Claude  J.; Pecock, S.; Eeles, R.; Cook, M.; Chu, C.; Nogués, C.; Lasset, C.; Berthet, P.; Meijers-Heijboer, H.; Gerdes, A-M.; Olsson, H.; Caldes, T.; van Leeuwen, FE.; Rookus, MA. Oral contraceptives and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS): A Report from Embrace, Genespo, Geo-Hebron, and the IBCCS Collaborating Group. J Clin Oncol 2007;25(25):1-7.

pilTillbaka upp
pil Tillbaka till Forskning

CANCER I HUVUD-HALS REGIONEN och ÖVRE DIGESTIONSKANALEN

Annertz K, Anderson H, Biörklund A, Möller T, Kari S, Mork J, Olsen J, Wennerberg J: Incidence and survival of carcinoma of the tounge in Scandinavia, with special reference to young adults. Int J Ca 2002; 101:95-99.

Wahlberg P, Anderson H, Biorklund A, Moller T, Perfekt R: Carcinoma of the parotid and submandibular glands--a study of survival in 2465 patients. Oral Oncol. 2002;38:706-713.

Wahlberg P, Anderson H, Biörklund A, Möller T: Carcinoma of the hypopharynx - analysis of incidence and survival in Sweden over a 30-year period. Head & Neck 1998;20:714-719.

Walther C, Zilling T, Perfekt R, Möller T: Increasing prevalence of adenocarcinoma of the oesophagus and gastro-oesophageal junction. A study based on the Swedish population between 1970 and 1997. Eur J Surg 2001;167:748-457.

Walther C, Zilling T, Perfekt R, Möller T: Adenocancer i esophagus och ventrikelns kardiaregion ökar kraftigt. Läkartidningen 2004;101:180-183.

pilTillbaka upp
pil Tillbaka till Forskning

MALIGNT MELANOM

Deskriptiva studier
Måsbäck A, Westerdahl J, Ingvar C, Olsson H, Jonsson N: Cutaneous malignant melanoma in South Sweden 1965, 1975, and 1985. A histopathologic review. Cancer 1994;73:1625-30.

Lindholm C, Andersson R, Dufmats M, Hansson J, Ingvar C, Moller T, Sjodin H, Stierner U, Wagenius G; Swedish Melanoma Study Group: Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors. Cancer. 2004;101:2067-2078.

Studier över riskfaktorer
Westerdahl J, Olsson H, Ingvar C, Brandt L, Jönsson P-E, Möller T: Southern travelling habits with special reference to tumour site in swedish melanoma patients. Anticancer Res 1992;12:1539-1542.

Westerdahl J, Olsson H, Måsbäck A, Ingvar C, Jonsson N, Brandt L, Jönsson P-E, Möller T: Use of sunbeds or sunlamps and malignant melanoma in southern Sweden.  Am J Epidemiol 1994;140:691-9.

Westerdahl J, Måsbäck A, Ingvar C, Jonsson N, Olsson H. Risk of cutaneous malignant melanoma in relation to use of sunbeds. Further evidence for UV-A carcinogenicity. Br J Cancer 2000;82(9):1593-99.

Westerdahl J, Olsson H, Måsbäck A, Ingvar C, Jonsson N. Is the use of sunscreens a risk factor for malignant melanoma. Melanoma Res 1995;5:59-65.

Måsbäck A, Westerdahl J, Ingvar C, Olsson H, Jonsson N: Clinical and histopathological characteristics in relation to aetiological risk factors in cutaneous melanoma: a population-based study. Melanoma Res 1999;9: 1-9.

Studier över prognostiska faktorer
Måsbäck A, Westerdahl J, Ingvar C, Olsson H, Jonsson N: Cutaneous malignant melanoma in Southern Sweden 1965, 1975 and 1985. Prognostic factors and histologic correlations. Cancer 1997;79:275-283.

Måsbäck A, Olsson H, Westerdahl J, Ingvar C, Johnson N. Prognostic factors in invasive cutaneous malignant melanoma.  A population-based study including a review. Melanoma Research 2001;11:435-45.

Informationsprogram på CD-ROM
Möller T, Hult C, Isacsson Å, Lindholm L: Multimedia techniques in the primary and secondary prevention of malignant melanoma. In: Skin Cancer and UV-radiation (Eds. Altmeyer P, Hoffman K, Stücker M). Springer Berlin 1997, p 930-941.

pilTillbaka upp
pil Tillbaka till Forskning

BEN- OCH MJUKDELSSARKOM

Deskriptiva studier
Alvegård T, Bauer H, Blomqvist C, Rydholm A, Smeland S: The Scandinavian Sarcoma Group - Background,organization and the SSG Register - The first 25 years. In: The Scandinavian Sarcoma Group - 25 years´ experience (Eds. Alvegård T, Rydholm A). Acta Orthop Scand 2004;75 Suppl 311:1-7.

Bauer H, Alvegård T, Berlin Ö, Erlanson M, Kalén A, Lindholm P, Gustafsson P, Smeland S, Trovik C: The Scandinavian Sarcoma Group Register 1986-2001. In: The Scandinavian Sarcoma Group - 25 years´ experience (Eds. Alvegård T, Rydholm A). Acta Orthop Scand 2004;75 Suppl 311:8-10.

Bauer H.C.F, Trovik C.S, Alvegård T.A, Berlin Ö, Erlansson M, Gustafson P, Klepp R, Möller T, Rydholm A, Saeter G, Wahlström O, Wiklund T:Monitoring Referral and Treatment in Soft Tissue Sarcoma: Study based on 1851 patients from the Scandinavian Sarcoma Group Register. Acta Orthop Scand 2001;72(2):150-159.

Studier över riskfaktorer
Eriksson M, Hardell L, Berg N O, Möller T, Axelsson O: Soft-tissue sarcomas and exposure to chemical substances; a case-referent study. British Journal of Industrial Medicine 1981;38:27-33.

Olsson H: An updated review of the epidemiology of soft tissue sarcoma. Acta Orthop Scand 2004;75 Suppl 311:16-20.

Merletti F, Richiardi L, Bertoni F, Ahrens W, Buemi A, Costa-Santos C, Eriksson, M.; Guenel, P.; Kaerlev, L.; Jockel, K. H.; Llopis-Gonzalez, A.; Merler, E.; Miranda, A.; Morales-Suarez-Varela, M. M.; Olsson, H.; Fletcher, T.; Olsen, J. Occupational factors and risk of adult bone sarcomas: a multicentric case-control study in Europe. Int J Cancer 2006;118(3):721-7.

Studier över prognostiska faktorer
Alvegård T A, Berg N O, Baldetorp B et al: Cellular DNA content and prognosis of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience. J Clin Oncol 1990;8:538-47.

Gustafson P, Åkerman M, Alvegård T A et al: Prognostic information in soft tissue sarcoma using tumour size, vascular invasion and microscopic tumour necrosis – the SIN system. Eur J Cancer 2003;39:1568-76.

Choong P F, Åkerman M, Willén H et al: Prognostic value of Ki-67 expression in 182 soft tissue sarcomas. Proliferation – a marker of metastasis? Apmis 1994;102:915-24.

Engellau J, Åkerman M, Anderson H, Domanski H A, Rambeck E, Alvegård T A, Nilbert M: Tissue microarray technique in osft tissue sarcoma: immunohistochemical Ki-67 expression in malignant fibrous histiocytoma. Applied Immunohistochemistry & Molecular Morphology 2001;9(4):358-63.

Engellau J, Persson A, Bendahl P-O, Åkerman M, Domanski H A, Bjerkehagen B, Lilleng P, Weide J, Rydholm A, Alvegård T A, Nilbert M: Expression profiling using tissue microarray in 211 malignant fibrous histiocytomas confirms the prognostic value of Ki-67. Virchows Archiv 2004;445:224-30.

Engellau J, Anderson H, Rydholm A, Bauer H C F, Sundby Hall K, Gustafson P, Åkerman M, Meis-Kindblom J, Alvegård T A, Nilbert M: Time-dependence of prognostic factors for patients with soft tissue sarcoma: a Scandinavian Sarcoma Group study of 338 malignant fibrous histiocytomas. Cancer 2004;100:2233-41.

Trial SSG I
Adjuvant chemotherapy for localised respectable soft tissue sarcoma in adults. Sarcoma Meta-analysis Collaboration (SMAC). Cochrane Database Syst Rev 2000:CD001419.

Sarcoma Meta-analysis Collaboration: Adjuvant chemotherapy for localised respectable soft-tissue sarcoma of adults: meta-analysis of individual data. Lancet 1997;350:1647-54.

pilTillbaka upp
pil Tillbaka till Forskning

BRÖSTCANCER

Deskriptiva studier
Engeland A, Haldorsen T, Dickman P, Hakulinen T, Möller T, Storm H, Tulinius H: Relative survival of cancer patients: A comparison between Denmark and the other Nordic countries. Acta Oncologica 1998;37:49-59.

Christensen L, Engholm G, Ceberg J, Hein S, Perfekt R, Tange U, Andersson M, Mouridsen H, Möller T, Storm HH: Can the survival difference between breast cancer patients in Denmark and Sweden in 1989 and 1994 be explained by patho-anatomical variables? A population-based study. Eur J Ca 2004; 40:1233-1243.

Christensen L, Engholm G, Cortes R, Ceberg J, Tange U, Andersson M, Bladström A, Mouridsen H, Möller T, Storm H H: Reduced mortality for women with mammography-detected breast cancer in east Denmark and south Sweden. Eur J Ca (Accepted)

Ravnsbæk Jensen A, Garne J P, Storm H H, Engholm G, Möller T, Overgaard J: Does stage at diagnosis explain the difference in survival after breast cancer in Denmark and Sweden? Acta Oncologica 2004;43:719-726.

Studier över riskfaktorer
Olsson H, Möller T, Ranstam J: Early Oral Contraceptives Use and Breast Cancer Among Premenopausal Women: Final Report From a Study in Southern Sweden. Journal of National Cancer Institute 1989;81:1000-1004.

Jernstrom H, Loman N, Johannsson OT, Borg A, Olsson H. Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing. Eur J Cancer 2005;41(15):2312-20.

Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative re-analysis of individual data on 53, 000  women with breast cancer and 100, 000 women without breast cancer from 54 epidemiological studies. Lancet 1996;347:1713-27.

Olsson H, Bladström A, Ingvar C, Möller T: A population-based cohort study of HRT use and breast cancer in southern Sweden. Br J Ca 2001; 85:674-677. 21.

Olsson H, Ingvar C, Bladström A. Hormone replacement therapy containing progestins and given continuously especially increases breast cancer risk in southern Sweden. Cancer 2003;97(6):1387-92.

Collaborative Group on Hormonal Factors in Breast Cancer: Breast  cancer and hormonal replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 23 705 women with breast cancer and 108 411 women without breast cancer. The Lancet  1997;350:1047-1059.

Studier över prognostiska faktorer
Sigurdsson H, Baldetorp B, Borg Å, Fernö M, Killander D, Olsson H. Prognostic indicators in node-negative breast cancer. N Engl J Med 1990;323(19):1348-49.

Guinee V F, Olsson H, Möller T, Hess K R, Taylor S H, Fahey T, Gladikov J V, van den Blink J, Bonichon F, Dische S, Yates J W, Cleton F J: Effect of pregnancy on prognosis for young women with breast cancer. The Lancet 1994;343:1587-1589.

Guinee V, Olsson H, Möller T, Shallenberger R, van den Blink J W, Peter Z, Durand M, Dische S, Cleton F, Zewuster R, Cui  M F, Lane W, Richter R: The prognosis of breast cancer in males. Cancer 1993;71:154-161.

Undervisningsprogram på CD-ROM
Möller T, Amadori D, Bellos G, Cancian M, Gravgaard A-M, Ioannidou-Mouzaka L, Marotta M, van Dongen J, wanrooij B, Lindhom LH: Interactive training for the management of breast cancer in general practice in Europe. J Cancer Education 2002; 17:19-23.

pilTillbaka upp
pil Tillbaka till Forskning

TESTISTUMÖRER

Despriptiva behandlingsstudier
Klepp O, Flodgren P, Maartman-Moe H, Lindholm CE, Unsgaard B, Teigum H, Fosså SD, Paus E. Ann Oncol. 1990 Jul;1(4):281-8.

Klepp O, Dahl O, Flodgren P, Stiener U, Olsson AM, Oldbring J, Nilsson S, Daehlin L, Tørnblom M, Småland R, Starkhammar H, Abramsson L, Wist E, Raabe N, Edekling T, Cavallin-Ståhl E. Eur J Cancer. 1997 Jun;33(7):1038-44.

Aass N, Klepp O, Cavallin-Ståhl E, Dahl O, Wicklund H, Unsgaard B, Baldetorp L, Ahlström S, Fosså SD. J Clin Oncol. 1991 May;9(5):818-26.

Studier över prognostiska faktorer
Klepp O, Olsson AM, Henrikson H, Aass N, Dahl O, Stenwig AE, Persson BE, Cavallin-Ståhl E, Fosså SD, Wahlqvist L. J Clin Oncol. 1990 Mar;8(3):509-18.

Studier over seneffekter
Eberhard J, Ståhl O, Giwercman Y,  Cwikiel M, Cavallin-Ståhl E, Lundin KB, Flodgren P, Giwercman A. Hum Reprod. 2004 Jun;19(6):1418-25. Epub 2004 Apr 22.

Brydøy M, Fosså SD, Klepp O, Bremnes RM, Wist EA, Wentzel-Larsen T, Dahl O. J Natl Cancer Inst. 2005 Nov 2;97(21):1580-8.

Ståhl O, Eberhard J, Jepson K, Spano M, Cwikiel M, Cavallin-Ståhl E, Giwercman A. Hum Reprod. 2006 Dec;21(12):3199-205. Epub 2006 Aug 24.

pilTillbaka upp
pil Tillbaka till Forskning

THYREOIDEACANCER

Studier över prognostiska faktorer
Tennvall J, Biörklund A, Möller T, Ranstam J, Åkerman M: Prognostic factors of papillary, follicular and medullary carcinomas of the thyroid gland. Acta Radiologica Oncology 1985;24:17-24.

Tennvall J, Biörklund A, Möller T, Ranstam J, Åkerman M: Is the EORTC-prognostic index of thyroid cancer valid on differentiated thyroid carcinoma? Retrospective multivariate analysis of differentiated thyroid carcinoma with long follow-up. Cancer 1986;57:1405-1414.

pilTillbaka upp
pil Tillbaka till Forskning

MALIGNA LYMFOM

Deskriptiva studier
Brandt L, Brandt J, Olsson H, Anderson H, Möller T: Gender and time differences in initial location and histological grade of non-Hodgkin lymphomas in Southern Sweden. Acta Oncologica 2001;40:479-484.

Studier riskfaktorer
Olsson H, Brandt L. Supradiaphragmatic presentation of non-Hodgkin's lymphoma in men occupationally exposed to organic solvents. Acta Med Scand 1981;210:415-18.

Olsson H, Brandt L. Risk of non-Hodgkin's lymphoma among men occupationally exposed to organic solvents. Scand J Work Environ Health 1988;14:246-51.

Dryver E, Brandt L, Kauppinen T, Olsson H. Occupational exposures and non-Hodgkin's lymphoma in Southern Sweden. Int J Occup Environ Health 2004;10(1):13-21.

Blomberg J, Möller T, Olsson H, Anderson H, Jonsson M: Cancer morbidity in blood recipients - Results of a cohort study. Eur J Cancer 1993;29A:2101-5.

Brandt L, Brandt J, Olsson H, Anderson H, Möller T: Blood transfusion as risk factor for non-Hodgkin lymphoma. Br J Cancer 1996;73:1148-1151.

Anderson H, Brandt L, Ericsson A, Möller T, Olsson H: Blood transfusion at child delivery and risk of subsequent malignant lymphoma in the mother. Vox Sang 1998;75:145-148.

Studier över prognostiska faktorer
Guinee VF, Giacco GG, Durand M, van den Blink JW, Gustavsson A, McVie JG, Zewuster R, Dische S, Fahey T, Lane W: The prognosis of Hodgkin's disease in older adults. J Clin Oncol. 1991 Jun;9(6):947-53

pilTillbaka upp
pil Tillbaka till Forskning

OVARIALCANCER

Collaborative Group on Epidemiological Studies of Ovarian Cancer: Ovarian cancer and oral contraceptives: collaborative reanalysi of data from 45 epidemiologocal studies including 23 257 womwn with ovarian cancer and 87 303 controls. Lancet 2008;371:303-14.

pilTillbaka upp

BARNTUMÖRER

Kohortstudier
Garwicz S, Möller T, Olsen JH, Sankila R : Nordic studies on late effects of treatment of cancer in childhood and adolescence. Acta Oncologica 2004:43:682-683.

Olsen J, Garwicz S, Hertz H, Jonmundsson G, Langmark F, Lanning M, Lie S, Moe P J, Möller T, Sankila R, Tulinius H: Second neoplasms after cancer in childhood and adolescence - A population-based study in the five Nordic countries. Br Med J 1993;307:1030-6.

Sankila R, Garwicz S, Olsen J, Döllner H, Hertz H, Kreuger A, Langmark F, Lanning M, Möller T, Tulinius H: Risk of subsequent malignant neoplasms among 1641 Hodgkin´s disease patients diagnosed in childhood and adolescence. A population-based cohort study in the five Nordic countries. J Clin Oncol  1996;14:1442-1446.

Sankila R, Olsen J, Anderson H, Garwicz S, Glattre E, Herz H, Langmark F, Lanning M, Möller T, Tulinius R: Risk of cancer among offspring of childhood cancer survivors. N Engl J Med 1998;338:1339-1344.

Winther J F, Sankila R, Tulinius H, Barlow L, Glattre E, Langmark F, Möller T, Olafsdottir GH, Ritvanen A, Olsen JH: Cancer in siblings of children with cancer in the Nordic countries: a population-based cohort study. The Lancet 2001:354 Sept 1: 711-717.

Möller T, Garwicz S, Perfekt R, Barlow L, Olsen J, Falk Winther J, Sankila R, Ritvanen A, Tulinius H, Olafsdottir G, Glattre E: Decreased mortality in 5-year survivors of cancer in childhood and adolescence: A population based study in the Nordic countries. J Clin Oncol 2001;19:3173-3181.

Möller TR, Garwicz S, Perfekt R, Barlow L, Falck Winther J, Glattre E, Olafsdottir G, Olsen JH, Ritvanen A, and Sankila R : Late Mortality among Five-Year Survivors of Cancer in Childhood and Adolescence: Differences between the Nordic Countries Acta Oncol 2004;43:711-718.

Fall-kontrollstudier
Garwicz S, Anderson H, Olsen j, Döllner H, Hertz H, Jonmundsson G, Langmark F, Lanning M, Möller T, Sankila R, Tulinius H: Second malignant neoplasms after cancer in childhood and adolescence: A population-based case-control study in the Nordic countries. Int J Ca 2000;88:672-678.

Svahn-Tapper G, Garwicz S, Anderson H, Shamsaldin A, De Vathaire F, Olsen JH, Døllner H, Hertz H, Jonmundsson G, Langmark F, Lanning M, Sankila R, Möller T: Radiation dose and relapse are predictors for development of second malignant solid tumors after cancer in childhood and adolescence: A population-based case-control study in the five Nordic countries. Acta Oncol. 2006:45:438-448.

Guerin S, Dupuy A, Anderson H, Shamsaldin A, Svahn-Tapper G, Moller T, Quiniou E, Garwicz S, Hawkins M, Avril MF, Oberlin O, Chavaudra J, de Vathaire F: Radiation dose as a risk factor for malignant melanoma following childhood cancer. Eur J Cancer 2003;39:2379-2386.

pilTillbaka upp
pil Tillbaka till Forskning

CANCERRISK VID SPECIFIKA EXPONERINGAR

Englander V, Sjöberg A, Hagmar L, Attewell R, Schutz A, Möller T, Skerfving S: Mortality and cancer morbidity in workers exposed to sulphur dioxide in a sulphuric acid plant. Int Arch Occup Environ Health 1988;61:157-162.

Svensson B-G, Englander V, Åkesson B, Attewell R, Skerfving S, Ericson Å, Möller T: Deaths and Tumors Among Workers Grinding Stainless Steel. American Journal of Industrial Medicine 1989;15:51-59.

Hagmar L, Åkesson B, Nielsen J, Andersson C, Lindén K, Attewell R, Möller T: Mortality and Cancer Morbidity in Workers Exposed to Low Levels of Vinyl Chloride Monomer at a Polyvinyl Chloride Processing Plant. Am J Indust Med 1990;17:553-565.

Svensson B-G, Nise G, Englander V, Attewell R, Skerfving S, Möller T: Deaths and tumours among rotogravure printers exposed to toluene. British Journal of Industrial Medicine 1990;47:372-379.

Hagmar L, Bellander T, Andersson C, Lindén K, Attewell R, Möller T: Cancer morbidity in nitrate fertilizer workers. Int Arch Occup Environ Health 1991;63:63-67.

Hagmar L, Linden K, Nilsson A, Norrving B, Åkesson B, Möller T: Cancer incidence and mortality among Swedish Baltic Sea fishermen. Scand J Work Environ Health 1992;18:217-224.

Olsson H, Brandt L, Möller T, Ranstam J: Prior irradiation as a risk factor for various tumour types. In: Radiation and Cancer Risks (Eds. Brustad T, Langmark F, Reitan J). Hemisphere, New York 1989; p 131-137.

Lönn S, Ahlbom A, Hall PO, Feychting M and the Swedish Interphone Group: Long-term mobile phone use and brain tumor risk. Am J Epid 2005.

Ahrens W, Mambetova C, Bourdon-Raverdy N, Llopis-González A, Guénel P, Hardell L, Merletti F, Morales-Suárez-Varela M, Olsen J, Olsson H, Vyberg M, Zambon P: Occupational exposure to endocrine disrupting compounds and biliary tract cancer in men. Results from a European multi-center case-control study. Scand J work Environ Health (in press) 2007.

Ahrens W, Timmer A, Vyberg M, Fletcher T, Guenel P, Merler E, Merletti F, Morales-Suarez-Varela M, Olsson,H, Olsen,J, Hardell L, Kaerlev L, Raverdy N, Lynge E: Risk factors for extrahepatic biliary tract carcinoma in men: medical conditions and lifestyle: Results from a European multicentre case-control studyEur J. Eur J Gastroenterol Hepatol 2007;19(8):623-30.

pilTillbaka upp
pil Tillbaka till Forskning

CANCERFÖREKOMST VID VISSA SJUKDOMAR/MEDICINSKA ÅTGÄRDER

Gudmundsson S, Möller T, Olsson H: Cancer incidence after cholecystectomy - a cohort study with thirty years follow-up. Europ J Surg Oncol 1989;15:113-117.

Lewold S, Olsson H, Gustafsson P, Lidgren L, Rydholm A. Overall cancer incidence not increased after prosthetic knee replacement: 14,551 patients followed for 66,622 person-years. Int J Cancer 1996;68:30-33.

Olsson H, Hägglund G. Reduced cancer morbidity and mortality in a prospective cohort of women with distal forearm fractures. Am J Epidemiol 1992;136(4):422-27.

Nived O, Bengtsson A, Jönsen A, Sturfelt G, Olsson H. Malignancies during follow up in an epidemiologically defined systemic lupus erythematous incipient cohort in southern Sweden. Lupus 2001;10(7)(500-4).

Westman K, Bygren P, Olsson H, Ranstam J, Wieslander J. Relapse rate, renal survival and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement. J Am Soc Nephrology 1998;May 9(5):842-52.

Geborek P, Bladstrom A, Turesson C, Gulfe A, Petersson IF, Saxne T, et al. Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas. Ann Rheum Dis 2005;64(5):699-703.

Lindholm LH, Anderson H, Ekbom T, Hansson L, Lanke J, Dahlöf B, de Faire U, Forsén K, Hedner T, Linjer E, Schersten B, Wester P-O, Möller TR: Relation between drug treatment and cancer in hypertensives in the Swedish Trial in Old Patients with Hypertension-2: a 5-year, prospective randomised controlled trial. The Lancet 2001;358 Aug 18:539-544.

pilTillbaka upp
pil Tillbaka till Forskning

HÄLSOEKONOMI m m

Möller T, Engström M, Ceberg J, Andersson I, Lindqvist R, Stenbeck M, Spetz C-L, Höjgård S,Dozet A, Lyttkens C-H: Country report: Sweden. OECD Study on cross-national differences in treatment, costs, and outcomes in breast cancer.  Organisation  for Economic Co-operation and Development, Paris 2000.

Tennvall J, Möller T, Attewell R: Delaying factors in primary treatment of breast cancer. Acta Chir Scand 1990;156:591-596.

Lindqvist R, Moller TR, Stenbeck M, Diderichsen F: Do changes in surgical procedures for breast cancer have consequences for hospital mean length of stay? A study of women operat-ed on for breast cancer in Sweden, 1980-95. Int J Technol Assess Health Care 2002;8:566-575.

Lindqvist R, Alvegård T, Jönsson P-E, Stenbeck M: Hospital stay related to TNM stage and the surgical procedure in primary breast cancer. Acta Oncologica 2004;43:545-550.

Hjelmgren J; Ceberg J; Persson U; . Alvegård TA: The cost of treatig pancreatic cancer: A cohort study based on patients´records from four hospitals in Sweden. Acta oncologica (Acta oncol.) 2003, 42: 218-226.

Möller T, Brorsson B, Ceberg J, Frödin J-E, Lindholm Ch, Nylén U, Perfekt R for the SBU Survey Group: A Prospective Survey of Radiotherapy Practice 2001 in Sweden. Acta Oncologica 2003;42:387-410.

Norlund A for the SBU Survey Group: Costs of Radiotherapy. Acta Oncologica 2003;42.410-415.

pilTillbaka upp
pil Tillbaka till Forskning

AKADEMISKA AVHANDLINGAR i vilka avdelningen medverkat
med material och/eller statistisk/epidemiologisk expertis

Olsson H: Epidemiological studies in malignant lymphoma. Lund 1984.

Tennvall J: Carcinoma of the thyroid. Preoperative diagnosis and prognostic factors. Lund 1984.

Alvegård T A: Management and prognosis of patients with high-grade soft tissue sarcomas. An evaluation of a Scandinavian joint care program. Lund 1989.

Johnson A: Flow cytometric clonal excess analysis in non-Hodgkin´s lymphoma. Diagnostics and clinical aspects. Lund 1991.

Lundgren R. Cytogenetic studies of prostatic cancer. Lund 1991.

Klepp O: Nonseminomatous germ cell testis cancer: Therapeutic outcome and prognostic factors. Trondheim 1991.

Aass N: Malignant germ cell tumours: survival and side effects. Oslo 1991.

Staël von Holstein C: Gastric stump carcinoma. A clinical study on carcinoma in the gastric remnant after surgery for benign gastroduodenal disease. Lund 1992.

Ranstam J: Oral contraceptives and breast cancer. Malmö 1992.

Strömblad L-G: Malignant astrocytomas. Studies in diagnosis and treatment. Lund 1993.

Gustafson P: Soft tissue sarcoma. Epidemiology and prognosis in 508 patients. Lund 1994.

Stewénius J: Ulcerative colitis and indeterminate colitis in a defined population – an epidemiological and clinical study.  Malmö 1995.

Westerdahl J: Malignant melanoma – risk factors. Lund 1995.

Johnsson A: Pharmacokinetic and pharmacodynamic studies on cisplatin in mice and men. Lund 1996.

Garne J P: Invasive breast cancer in Malmö 1061-1992. Malmö 1996.

Månsson Å: The patient with bladder cancer. From symptoms, through treatment, with special reference to psychosocial consequences of radical cystectomy. Lund 1997.

Hedberg M: Pancreatic carcinoma in Malmö, Sweden. Clinical, epidemiological and biochemical aspects. Malmö 1998.

Bratt O: Familial and hereditary prostate cancer. Lund 1999.

Kiekbusch S: Prävention im Rahmen von Community Medicine - eine explorative Studie am Beispiel des malignen Melanoms. Institut für Medizinische Psychologie, Ernst-Moritz-Arndt-Universität Greifswald 1999.

Skytting B: Synovial sarcoma - A Scandinavian Sarcoma Group project. KI, Stockholm 1999.

Trovik C: Local recurrence of soft tissue sarcoma - A Scandinavian Sarcoma Group Project. Bergen and Stockholm 2001.

Jerkeman M: Aggressive lymphoma. Lund 2000.

Planck M: Hereditary nonpolyposis colorectal cancer. Molecular genetics and biology of associated tumors. Lund 2002.
Måsbäck A: Malignant melanoma in southern Sweden; Histopathology, Prognosis and Aetiology. Lund 2002.

Idvall I: Ductal carcinoma in situ of the breast. Histopathological and cell biological factors; their relationship to mode of detection and to subsequent ipsilateral and contralateral tumours. Lund 2003.

Ösby E: Clinical studies in aggressive non-Hodgkin´s lymphoma with special reference to elderly patients. Stockholm 2003.

Holmberg E. Methodological aspects on excess cancer risk after exposure to ionizing radiation. Göteborg 2004.

De Vries E: Trends and risk factors of cutaneous melanoma in Europe. Rotterdam 2004.

Engellau J: Prognostic factors in soft tissue sarcoma. Tissue microarray for immunostaining, the importance of whole-tumor sections and time-dependence. Lund 2004.

Ravnsbæk Jensen A: A comparative population based study on breast cancer patients in Denmark and Sweden - Aspects of early diagnosis, axillary surgery and registration. Århus 2004.

Lönn S: Mobile phone use and risk of intracranial tumors. KI, Stockholm 2004.

Ericson K. Tumors associated with HNPCC: Defective mismatch repair and familial risk of cancer. Lund 2005.
Lindkvist R: Hospital length of stay – Register-based studies on breast cancer surgery. KI , Stockholm 2005.

Liedberg F: Invasive bladder cancer – aspects on staging and prognosis. Lund 2006.

Engström K: Clinical and molecular studies of liposarcoma. Göteborg 2007.

Fernebro J: Soft tissue sarcoma patterns multiplicity, heterogeneity and growth characteristics. Lund 2007.

Francis P: Genetic profiling in soft tissue sarcoma. Lund 2007.

Halvarsson B. Morphological features and mismatch repair in colorectal tumors. Lund 2007.

pilTillbaka upp
pil Tillbaka till Forskning


Uppdaterad: 2008 01 31
Mona Martinsson Svensson
E-post: ocsyd@med.lu.se